Altfest L J & Company Has Decreased Amgen (AMGN) Holding By $1.23 Million; Second Curve Capital Has Upped Banc Of California (BANC) Position

April 20, 2018 - By Adrian Mccoy

Amgen Inc. (NASDAQ:AMGN) Logo

Altfest L J & Company Inc decreased Amgen Inc. (AMGN) stake by 54.58% reported in 2017Q4 SEC filing. Altfest L J & Company Inc sold 7,127 shares as Amgen Inc. (AMGN)’s stock declined 2.99%. The Altfest L J & Company Inc holds 5,930 shares with $1.03 million value, down from 13,057 last quarter. Amgen Inc. now has $114.45 billion valuation. The stock decreased 0.97% or $1.67 during the last trading session, reaching $171.26. About 1.70 million shares traded. Amgen Inc. (NASDAQ:AMGN) has risen 3.78% since April 20, 2017 and is uptrending. It has underperformed by 7.77% the S&P500.

Second Curve Capital Llc increased Banc Of California Inc (BANC) stake by 300% reported in 2017Q4 SEC filing. Second Curve Capital Llc acquired 105,000 shares as Banc Of California Inc (BANC)’s stock declined 11.29%. The Second Curve Capital Llc holds 140,000 shares with $2.89 million value, up from 35,000 last quarter. Banc Of California Inc now has $947.26M valuation. The stock increased 1.22% or $0.225 during the last trading session, reaching $18.725. About 154,943 shares traded. Banc of California, Inc. (NYSE:BANC) has declined 9.16% since April 20, 2017 and is downtrending. It has underperformed by 20.71% the S&P500.

Since February 1, 2018, it had 1 insider purchase, and 0 insider sales for $386,000 activity. Bogler John A. had bought 20,000 shares worth $386,000 on Thursday, February 1.

Among 12 analysts covering Banc of California (NYSE:BANC), 7 have Buy rating, 1 Sell and 4 Hold. Therefore 58% are positive. Banc of California had 30 analyst reports since November 9, 2015 according to SRatingsIntel. Keefe Bruyette & Woods maintained it with “Hold” rating and $2200 target in Monday, June 5 report. The firm has “Hold” rating by FBR Capital given on Thursday, February 8. UBS initiated Banc of California, Inc. (NYSE:BANC) on Monday, May 23 with “Buy” rating. Wells Fargo initiated Banc of California, Inc. (NYSE:BANC) on Monday, May 2 with “Outperform” rating. The firm has “Underperform” rating by Bank of America given on Friday, April 6. B. Riley & Co downgraded the stock to “Neutral” rating in Thursday, February 1 report. Wood downgraded Banc of California, Inc. (NYSE:BANC) on Friday, May 5 to “Market Perform” rating. The company was upgraded on Thursday, January 26 by FBR Capital. On Thursday, October 20 the stock rating was maintained by FBR Capital with “Mkt Perform”. Keefe Bruyette & Woods maintained Banc of California, Inc. (NYSE:BANC) rating on Thursday, September 28. Keefe Bruyette & Woods has “Hold” rating and $20.0 target.

Investors sentiment decreased to 0.78 in Q4 2017. Its down 0.20, from 0.98 in 2017Q3. It worsened, as 22 investors sold BANC shares while 66 reduced holdings. 26 funds opened positions while 43 raised stakes. 56.03 million shares or 5.95% less from 59.57 million shares in 2017Q3 were reported. 9,580 were reported by Fifth Third Financial Bank. Patriot Fincl Prns Grp Limited Partnership has 2.85M shares for 30.29% of their portfolio. Teacher Retirement Of Texas holds 14,446 shares or 0% of its portfolio. Goldman Sachs Gru Incorporated accumulated 461,894 shares. Rhumbline Advisers invested 0% of its portfolio in Banc of California, Inc. (NYSE:BANC). Ubs Asset Mgmt Americas holds 0% or 10,800 shares. Millennium Management Ltd Com has 110,127 shares. Endeavour Incorporated reported 0.5% stake. Principal Financial, a Iowa-based fund reported 318,639 shares. Miles Inc owns 0.13% invested in Banc of California, Inc. (NYSE:BANC) for 10,981 shares. Swiss Bancshares invested 0% of its portfolio in Banc of California, Inc. (NYSE:BANC). King Luther Management stated it has 0.11% of its portfolio in Banc of California, Inc. (NYSE:BANC). Regions Financial reported 91 shares. Advisory Net Lc invested 0% in Banc of California, Inc. (NYSE:BANC). Continental Advsr Limited Liability Corporation has 184,500 shares for 0.82% of their portfolio.

Second Curve Capital Llc decreased Tristate Capital Holdings Inc (NASDAQ:TSC) stake by 82,044 shares to 1.18 million valued at $27.05 million in 2017Q4. It also reduced Zions Bancorporation (NASDAQ:ZIONW) stake by 213,300 shares and now owns 493,352 shares. Bancorp Inc Del (NASDAQ:TBBK) was reduced too.

Altfest L J & Company Inc increased Vanguard Telecommunications Services Etf (VOX) stake by 6,839 shares to 12,152 valued at $1.11 million in 2017Q4. It also upped Gilead Sciences Inc stake by 8,585 shares and now owns 12,263 shares. Lam Research Corp. (NASDAQ:LRCX) was raised too.

Since December 12, 2017, it had 0 insider buys, and 4 insider sales for $1.11 million activity. Harper Sean E had sold 1,525 shares worth $283,071.

Investors sentiment increased to 1.22 in 2017 Q4. Its up 0.23, from 0.99 in 2017Q3. It is positive, as 73 investors sold AMGN shares while 458 reduced holdings. 122 funds opened positions while 527 raised stakes. 551.71 million shares or 0.60% less from 555.05 million shares in 2017Q3 were reported. Macquarie Group Inc accumulated 197,318 shares. Joel Isaacson Ltd Liability Corp reported 0.1% in Amgen Inc. (NASDAQ:AMGN). Factory Mutual Insurance holds 87,250 shares. Hm Payson And holds 1.35% or 192,545 shares. Laurel Grove Cap Lc reported 3,167 shares. Zurcher Kantonalbank (Zurich Cantonalbank) holds 0.41% or 266,416 shares. Kings Point Capital Mngmt reported 17,637 shares or 0.64% of all its holdings. Systematic Fin Mngmt LP stated it has 0.06% in Amgen Inc. (NASDAQ:AMGN). James Inv Research reported 0.19% stake. Sigma Planning Corp holds 0.22% or 16,561 shares in its portfolio. Northside Cap Mngmt Lc stated it has 2,871 shares or 0.14% of all its holdings. Btr Capital Management Incorporated holds 0.05% or 1,320 shares. The Germany-based Dekabank Deutsche Girozentrale has invested 1.18% in Amgen Inc. (NASDAQ:AMGN). Parsec Fincl invested 1.58% in Amgen Inc. (NASDAQ:AMGN). Quantitative Inv Mngmt Ltd Liability Corp has invested 0.02% in Amgen Inc. (NASDAQ:AMGN).

Among 25 analysts covering Amgen Inc. (NASDAQ:AMGN), 11 have Buy rating, 0 Sell and 14 Hold. Therefore 44% are positive. Amgen Inc. had 88 analyst reports since August 3, 2015 according to SRatingsIntel. UBS maintained the shares of AMGN in report on Thursday, October 29 with “Buy” rating. The stock has “Neutral” rating by Credit Suisse on Friday, February 2. The stock of Amgen Inc. (NASDAQ:AMGN) has “Market Perform” rating given on Wednesday, June 29 by Bernstein. The stock of Amgen Inc. (NASDAQ:AMGN) has “Neutral” rating given on Wednesday, January 24 by JP Morgan. The rating was downgraded by Credit Suisse to “Neutral” on Tuesday, December 20. As per Thursday, September 7, the company rating was maintained by Piper Jaffray. On Friday, December 4 the stock rating was initiated by Wells Fargo with “Market Perform”. The rating was maintained by Barclays Capital on Thursday, April 5 with “Equal-Weight”. On Thursday, October 12 the stock rating was maintained by Piper Jaffray with “Buy”. RBC Capital Markets maintained Amgen Inc. (NASDAQ:AMGN) on Thursday, October 26 with “Hold” rating.

Amgen Inc. (NASDAQ:AMGN) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.